Jasper Therapeutics, Inc. (JSPRW) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $31.63M | +73.5% |
| 2024 | $18.23M | +10.8% |
| 2023 | $16.45M | +33.0% |
| 2022 | $12.37M | -48.7% |
| 2021 | $24.14M | +64.8% |
| 2020 | $14.65M | +35.0% |
| 2019 | $10.85M | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $31.63M | +73.5% |
| 2024 | $18.23M | +10.8% |
| 2023 | $16.45M | +33.0% |
| 2022 | $12.37M | -48.7% |
| 2021 | $24.14M | +64.8% |
| 2020 | $14.65M | +35.0% |
| 2019 | $10.85M | — |